Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Launches Patients’ Preference Project

This article was originally published in The Gray Sheet

Executive Summary

Associate director for science at FDA’s device center highlights ongoing efforts to incorporate more quantitative patient input in device reviews.

You may also be interested in...



Medical Device Innovation Consortium Sets Priorities To Advance Regulatory Science

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month: Heads of the newly formed private-public partnership comprising industry, academia, and FDA describe the group’s top three projects to advance medical device regulatory science.

Medical Device Innovation Consortium Sets Priorities To Advance Reg Science

The heads of the newly formed private-public partnership comprising industry, academia and FDA describe the group’s top three projects to advance medical device regulatory science.

FDA Takes Initial Steps To Quantify Patient Opinion

CDRH survey to quantify patients’ risk tolerance for obesity device therapies will begin soon, but some physicians and patient advocates are urging caution in applying the data.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT031613

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel